| P50 | author | Nuria Bargallo | Q42684490 |
| | Hugo Cesar Baggio | Q45591446 |
| | Barbara Segura | Q57317895 |
| | Carme Uribe | Q61134732 |
| | Alexandra Abós Ortega | Q64779281 |
| | Yaroslau Compta | Q64858233 |
| | Carme Junqué | Q38641038 |
| P2093 | author name string | Francesc Valldeoriola | |
| | Maria Jose Marti | |
| P2860 | cites work | “Mini-mental state” | Q25938989 |
| | Staging of brain pathology related to sporadic Parkinson's disease | Q28131702 |
| | Neuroanatomical correlates of impaired decision-making and facial emotion recognition in early Parkinson's disease | Q28257740 |
| | Parkinsonism: onset, progression, and mortality | Q28259134 |
| | Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia | Q28705235 |
| | The spectrum of cognitive disorders in Parkinson's disease: a data-driven approach | Q30593620 |
| | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease | Q30611520 |
| | Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment. | Q42981268 |
| | Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease. | Q45939734 |
| | New Clinical Subtypes of Parkinson Disease and Their Longitudinal Progression: A Prospective Cohort Comparison With Other Phenotypes. | Q47964796 |
| | Progression of cortical thinning in early Parkinson's disease | Q48308610 |
| | Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia. | Q48330240 |
| | Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. | Q48416681 |
| | Structural correlates of facial emotion recognition deficits in Parkinson's disease patients. | Q48491666 |
| | Cortical thinning associated with mild cognitive impairment in Parkinson's disease | Q48617569 |
| | Cortical hypoperfusion in Parkinson's disease assessed using arterial spin labeled perfusion MRI. | Q48813269 |
| | Reliability, validity, and clinical correlates of apathy in Parkinson's disease | Q48852465 |
| | Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness | Q48912954 |
| | Lewy body-related alpha-synucleinopathy in the aged human brain | Q50282783 |
| | Neuropathology of dementia in a large cohort of patients with Parkinson's disease. | Q50927595 |
| | Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. | Q51875573 |
| | Principal component analysis | Q55921966 |
| | Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment | Q87147783 |
| | Parkinson's Disease Society Brain Bank, London: overview and research | Q33463550 |
| | The neurobiological basis of cognitive impairment in Parkinson's disease | Q33724698 |
| | Initial cognitive decline is associated with cortical thinning in early Parkinson disease. | Q33927210 |
| | Pattern of regional cortical thinning associated with cognitive deterioration in Parkinson's disease | Q34566376 |
| | Anatomical heterogeneity of Alzheimer disease: based on cortical thickness on MRIs | Q34591279 |
| | Changes in network activity with the progression of Parkinson's disease | Q35679748 |
| | Cerebral perfusion and cortical thickness indicate cortical involvement in mild Parkinson's disease | Q36053272 |
| | Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process | Q36175217 |
| | Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines | Q36810589 |
| | Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. | Q36834550 |
| | Clinical diagnostic criteria for dementia associated with Parkinson's disease | Q36836828 |
| | Gray matter atrophy distinguishes between Parkinson disease motor subtypes | Q36870270 |
| | Principal component analysis of PiB distribution in Parkinson and Alzheimer diseases | Q37178758 |
| | A critical reappraisal of current staging of Lewy-related pathology in human brain | Q37204046 |
| | A critical evaluation of current staging of alpha-synuclein pathology in Lewy body disorders | Q37249041 |
| | Early cortical gray matter loss and cognitive correlates in non-demented Parkinson's patients | Q37381461 |
| | Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study | Q37401996 |
| | Early involvement of the cerebral cortex in Parkinson's disease: convergence of multiple metabolic defects | Q37501550 |
| | Systematic review of levodopa dose equivalency reporting in Parkinson's disease. | Q37808677 |
| | Neurochemistry and the non-motor aspects of PD. | Q38022038 |
| | Cognitive impairment in patients with Parkinson's disease: diagnosis, biomarkers, and treatment | Q38027731 |
| | Mild cognitive impairment and Parkinson's disease--something to remember. | Q38242150 |
| | Neuroimaging biomarkers for Parkinson disease: facts and fantasy | Q38264397 |
| | Biomarkers of cognitive decline in Parkinson's disease | Q38367451 |
| | The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort | Q38378476 |
| | Combined dementia-risk biomarkers in Parkinson's disease: a prospective longitudinal study | Q38452068 |
| | Non motor subtypes and Parkinson's disease | Q38605430 |
| | Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration. | Q39396387 |
| | The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia | Q39605807 |
| | Clinical subtypes of Parkinson's disease | Q39782935 |
| | Patterns of cortical thickness and surface area in early Parkinson's disease | Q39801507 |
| | Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson's disease. | Q42462932 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Parkinson's disease | Q11085 |
| P304 | page(s) | 699-708 | |
| P577 | publication date | 2016-04-20 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Patterns of cortical thinning in nondemented Parkinson's disease patients | |
| P478 | volume | 31 | |